Health informatics

Q&A: How artificial intelligence could transform health care

Health care has historically been slow to adopt new technologies that involve wholesale changes to the nature of the work. Witness the slow and checkered roll-out of electronic health records and the utter failure of prior ...

Diseases, Conditions, Syndromes

Wegovy cuts heart risks by 20% in large trial

In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.


US approves highly anticipated Eli Lilly weight loss drug

The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.

page 2 from 40